Showing results (471-480 of 995) with videos related to
Sort By:
Pageof 100
Magyar Onkologia|September 28, 2023
[Effects of 3D tissue structure on drug sensitivity - 3D bioprinted tissue mimetic structures in cancer research]Dorottya Moldvai, Dániel Sztankovics, Titanilla Dankó, et al.Magyar Onkologia|September 19, 2024
[Retrospective analysis of metaplastic breast cancer cases]Kinga Kolossváry, Réka Nagy, Eszter Papp, et al.Magyar Onkologia|March 12, 2026
[Very accelerated partial breast irradiation (VAPBI) with high-dose-rate interstitial brachytherapy following breast- conserving surgery of low-risk breast cancer patients]Norbert Mészáros, Viktor Smanykó, Tibor Major, et al.Magyar Onkologia|March 12, 2026
[Daily online adaptive irradiation of bladder tumors with individualized safety margin creation]Gabriella Dóra Pulugor, Ádám Gáldi, Levente Varga, et al.Magyar Onkologia|March 12, 2026
[Could the administration of immune checkpoint inhibitors be discontinued after 2 years of application? Pros and cons for the development of a national guideline.]László Mangel, Tímea Balatoni, Krisztina Bogos, et al.Magyar Onkologia|May 31, 2026
Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategiesPéter Nagy, Anna Kamilla Kis, Eszter Bajtai, et al.Magyar Onkologia|May 31, 2026
Ten years of translational innovation in HER2-targeted immune cell therapy - A comprehensive review of the work of the University of Debrecen Cell and Molecular Therapy Research GroupGyörgy Vereb, Árpád SzöőrMagyar Onkologia|May 31, 2026
[Successful selpercatinib treatment of metastatic medullary thyroid cancer carrying rare RET variant]Anna Kiss, Tamás Pintér, Mónika Révész, et al.Magyar Onkologia|May 31, 2026
[Investigating tumor cell motility under hypoxia and therapeutic resistance in cancer models]Eszter Sára SurgutaMagyar Onkologia|March 12, 2026
[rare subtype of kidney cancer - Pigmented microcystic chromophobe carcinoma]Luca Szalai, Imola Adamik, Judit Betenbuk, et al.Pageof 100